TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GEBE Medicinsk och Bioteknisk Konsult AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
32
|
29
|
19 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-5
|
166
|
-3 |
| EBITDA |
-6
|
161
|
-1 |
| Total assets |
302
|
353
|
185 |
| Current assets |
302
|
353
|
44 |
| Current liabilities |
33
|
34
|
3 |
| Equity capital |
263
|
314
|
179 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
87.1%
|
89.0%
|
96.8% |
| Turnover per employee |
16
|
14
|
10 |
| Profit as a percentage of turnover |
-15.6%
|
572.4%
|
-15.8% |
| Return on assets (ROA) |
-1.7%
|
47.0%
|
-1.6% |
| Current ratio |
915.2%
|
1038.2%
|
1466.7% |
| Return on equity (ROE) |
-1.9%
|
52.9%
|
-1.7% |
| Change turnover |
4
|
10
|
14 |
| Change turnover % |
13%
|
50%
|
229% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.